Ph3 lung cancer trial with high adjudication rate among central reviewers Jenny-Kate BarkinFebruary 5, 2019
Site/Central discordance: late phase oncology trial with differences between site and central reads found Jenny-Kate BarkinFebruary 5, 2019
